Veru to report fiscal 2023 first quarter financial results on february 9, 2023

Miami, fl, jan. 26, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a biopharmaceutical company focused on developing novel medicines for covid-19 and other viral ards-related diseases and for oncology, today announced it will host a conference call and audio webcast on thursday, february 9, 2023, at 8:00 a.m. et to discuss its fiscal 2023 first quarter financial results and provide a business update.
VERU Ratings Summary
VERU Quant Ranking